TRPV1 and atherosclerosis: Treatment with oxLDL, the most important modulator in the development of atherosclerosis, increased TRPV1 channel activity in BMDMs, as evidenced by a TRPV1-mediated increase in [Ca2+]i level to a profile similar to that evoked by TRPV1 agonists.